Retail traders have turned to Robinhood as a popular platform for trading stocks. With its user-friendly interface and commission-free trading, Robinhood has made stock trading accessible to a wider audience. Traders are particularly attracted to low-priced stocks, commonly known as penny stocks or cheap stocks. They can offer the potential for significant gains.
It’s important to note that low-priced stocks can be risky, however. They are often issued by smaller and less established companies, which can be more volatile and susceptible to fraud. Investors should thoroughly research before investing in cheap stocks. “Robinhood stocks” include companies that trade on the Nasdaq and NYSE. However, access to certain issuers, such as those traded on the Over The Counter exchange (OTC), is limited.
When we mention “cheap Robinhood stocks” in this article, we specifically refer to NYSE and NASDAQ stocks priced below $5. These stocks offer high potential returns but carry a high level of risk due to their volatility. Traders should exercise caution and have a clear strategy in place before making trades.
Finding Cheap Stocks On Robinhood
To find cheap Robinhood stocks to buy, traders can look for companies with solid fundamentals, such as strong earnings and revenue growth, and a clear path to profitability. It’s also possible to seek out companies that are operating in high-growth industries or have unique products or services. However, traders should always remember that even companies with strong fundamentals can experience significant price fluctuations.
With this in mind, let’s explore some of the cheap Robinhood stocks generating interest among traders right now. This also continued the list of stocks in the article “4 Cheap Robinhood Stocks Under $1 To Watch Trading For Pennies.”
Robinhood Stocks To Watch
Benitec Biopharma Inc. (BNTC)
Thanks to the stock market sell-off in 2022, there are plenty of cheap NASDAQ and NYSE stocks to watch. Benitec Biopharma is one of them, and traders are watching as BNTC stock has made a rebound in 2023. While there’s still a lot of room to makeup, the market has taken notice as Benitec has begun enrolling subjects into its clinical development program.
The gene therapy company started enrolling oculopharyngeal muscular dystrophy patients into the OPMD natural history phase of its BB-301 program. In a January update, CEO Jerel A. Banks, M.D., Ph.D. explained, “Following the initiation of OPMD patient screening at the lead clinical site in the United States in the fourth quarter of 2022, the Principal Investigator of the OPMD NH Study reported high enrollment interest from potential study subject.”
– Best Penny Stocks To Buy Now? 4 With Big News In February
One of the recent updates that may have raised some interest is what was discussed in its second quarter fiscal 2023 update. In particular, Benitec said that an Investigational New Drug (IND) application and Clinical Trial Application (CTA) clearance is expected in the Second Calendar Quarter of 2023 for North American markets. There’s also a CTA filing for a comprehensive BB-301 study, inclusive of a 6-month pre-treatment observation period, one day of BB-301 dosing, and a subsequent 52-week follow-up period planned for completion in the Second Calendar Quarter of 2023.
With Q2 incoming, these may be things the market is starting to pay closer attention to.
Sidus Space Inc. (SIDU)
Another one of the sub-$1 Robinhood stocks to watch is Sidus Space. Like most of the stocks trading for pennies, the company has been put through its paces over the last year. Sidus specializes in “Space-as-a-Service” and specifically commercial satellite design, manufacturing, and launch, among other things. It offers predictive analytics to customers as well.
SIDU stock fell earlier this quarter thanks to news of a new financing round. Now that the dust has settled and the company has fresh cash in hand, the market is looking for the next move to be made. Plans are for the cash to be used for sales and marketing, operational costs, product development, and manufacturing expansion. The funding came shortly before Sidus was awarded a $2.5 million project for The Netherlands Organization for Applied Scientific Research. The two will test the Organization’s laser communications technology on a Sidus LizzieSat satellite.
What are traders looking at now? This week the company presents at the Winter Wonderland investors conference. Founder and CEO, Carol Craig gives a presentation and will be available for one-on-one meetings to be held throughout the conference. With the market looking for more results, speculation has begun building.
Versus Systems Inc. (VS)
Shares of Versus Systems popped on Tuesday after retesting the 50-day moving average at the end of last week. The company specializes in engagement and rewards for live events, games, shows, and apps. Earlier this month, VS stock, dropped following the pricing of a $2.25 million financing round. Now that the dust has settled, however, markets are focusing on what comes next for Versus now that new capital is in hand.
– Penny Stocks & The Stock Market This Week Feb. 21-24
One of the hot topics of discussion traces back to an update from earlier in February. Versus announced plans to partner with Resolve Debt Inc. It will bring gamification and interactive elements to Resolve’s AI-driven credit and debt management products. Versus CEO Matthew Pierce emphasized the prospects of the deal in a related press release.
“It’s a new application for products and methods that we have long believed in. Our entire product suite has always been built around the effectiveness of interactivity and rewards to incentivize end users. Adding this expertise to Resolve’s generative AI platform will help more companies provide appropriate repayment solutions to consumers cost effectively, at scale.”
It may also be worth noting that VS is on the list of low-float stocks to watch. immediately prior to the last offering, the company said it had roughly 8.2 million shares outstanding.
List Of Robinhood Stocks To Watch
- Benitec Biopharma Inc. (NASDAQ: BNTC)
- Sidus Space Inc. (NASDAQ: SIDU)
- Versus Systems Inc. (NASDAQ: VS)
- Troika Media Group (NASDAQ: TRKA)
- Sorrento Therapeutics (NASDAQ: SRNE)
- Nogin Inc. (NASDAQ: NOGN)
- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON)